{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:37:28Z","timestamp":1784896648811,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ejps.2012.04.005","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T19:37:03Z","timestamp":1334691423000},"page":"530-536","source":"Crossref","is-referenced-by-count":17,"title":["Differentiating mucosal and hepatic metabolism of budesonide by local pretreatment with increasing doses of ketoconazole in the proximal jejunum"],"prefix":"10.1016","volume":"46","author":[{"given":"Janeric","family":"Seideg\u00e5rd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Borg\u00e5","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2012.04.005_b0005","first-page":"135","article-title":"Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation","volume":"40","author":"Bailey","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2012.04.005_b0010","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0009-9236(95)90032-2","article-title":"Disposition of intravenous and oral cyclosporine after administration with grapefruit juice","volume":"57","author":"Ducharme","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2012.04.005_b0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2036.2003.01426.x","article-title":"A pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (EntocortTM) capsules","volume":"17","author":"Edsb\u00e4cker","year":"2003","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2012.04.005_b0020","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003088-200443120-00003","article-title":"Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn\u2019s disease","volume":"43","author":"Edsb\u00e4cker","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2012.04.005_b0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/187231209789352085","article-title":"Revisiting the metabolism of ketoconazole using accurate mass","volume":"3","author":"Fitch","year":"2009","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.ejps.2012.04.005_b0030","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/hep.510240407","article-title":"Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin","volume":"24","author":"Fromm","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.ejps.2012.04.005_b0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0009-9236(03)00118-8","article-title":"Time course of recovery of cytochrome P450 3A function after single doses of grapefruit juice","volume":"74","author":"Greenblatt","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2012.04.005_b0040","first-page":"161","article-title":"Molecular and physical mechanisms of first-pass extraction","volume":"27","author":"Hall","year":"1999","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.ejps.2012.04.005_b0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/clpt.1992.171","article-title":"Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction","volume":"52","author":"Hebert","year":"1992","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2012.04.005_b0050","first-page":"1121","article-title":"The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism","volume":"24","author":"Holtbecker","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2012.04.005_b0055","first-page":"137","article-title":"Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver","volume":"23","author":"J\u00f6nsson","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2012.04.005_b0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2133\/dmpk.23.87","article-title":"Intestinal first-pass metabolism of CYP3A4 substrates","volume":"23","author":"Kato","year":"2008","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2012.04.005_b0065","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0140-6736(91)92302-I","article-title":"First-pass metabolism of cyclosporin by the gut","volume":"338","author":"Kolars","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2012.04.005_b0070","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1172\/JCI116064","article-title":"Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes","volume":"90","author":"Kolars","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2012.04.005_b0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0009-9236(95)90068-3","article-title":"Interaction between grapefruit juice and midazolam in humans","volume":"58","author":"Kupferschmidt","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2012.04.005_b0080","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1067\/mcp.2000.110216","article-title":"Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastin","volume":"68","author":"Lilja","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2012.04.005_b0085","first-page":"947","article-title":"Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test","volume":"22","author":"Lown","year":"1994","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2012.04.005_b0090","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2165\/00003088-198308040-00002","article-title":"Influence of food intake on presystemic clearance of drugs","volume":"8","author":"Melander","year":"1983","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2012.04.005_b0095","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ejps.2007.01.005","article-title":"A convenient method for local drug administration at predefined sites in the entire gastrointestinal tract: experiences from 13 phase I studies","volume":"30","author":"Nyberg","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2012.04.005_b0100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0009-9236(96)90162-9","article-title":"First-pass metabolism of midazolam by the human intestine","volume":"60","author":"Paine","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2012.04.005_b0105","first-page":"1552","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism","volume":"283","author":"Paine","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2012.04.005_b0110","first-page":"86","article-title":"Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid","volume":"122","author":"Ryrfeldt","year":"1982","journal-title":"Eur. J. Respir. Dis. Suppl."},{"key":"10.1016\/j.ejps.2012.04.005_b0115","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ejps.2008.07.005","article-title":"Presystemic elimination of budesonide in man when administered locally at different levels in the gut, with and without local inhibition by ketoconazole","volume":"35","author":"Seideg\u00e5rd","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2012.04.005_b0120","first-page":"461","article-title":"Grapefruit juice interaction with oral budesonide: equal effect on immediate-release and delayed-release formulations","volume":"64","author":"Seideg\u00e5rd","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejps.2012.04.005_b0125","first-page":"99","article-title":"Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction","volume":"15","author":"Shen","year":"1997","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2012.04.005_b0130","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0009-9236(96)90177-0","article-title":"Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism","volume":"59","author":"Thummel","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2012.04.005_b0135","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/0091270003256059","article-title":"Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice","volume":"43","author":"Veronese","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2012.04.005_b0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0169-409X(97)00041-0","article-title":"The barrier function of CYP3A4 and P-glycoprotein in the small bowel","volume":"27","author":"Watkins","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2012.04.005_b0145","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0009-9236(95)90168-X","article-title":"Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine","volume":"58","author":"Wu","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2012.04.005_b0150","first-page":"804","article-title":"Characterization of human small intestinal cytochromes P-450","volume":"27","author":"Zhang","year":"1999","journal-title":"Drug. Metab. Dispos."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098712001741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098712001741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T02:28:06Z","timestamp":1543026486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098712001741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0928098712001741"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2012.04.005","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}